Analyst	Recommendation	Action	Price target	Projected	Date
Joseph Moore Morgan Stanley	Sell	Reiterated	$12.60	+10.2%	07/28/2026
Quinn Bolton Needham	Buy	Reiterated	$21.00	+83.7%	07/28/2026
Blayne Curtis Jefferies	Hold	Maintained	$13.00	+13.7%	07/27/2026
Kevin Garrigan Jefferies	Hold	Maintained	$13.00	+13.7%	07/27/2026
Kevin Cassidy Rosenblatt Securities	Hold	Maintained	$13.00	+13.7%	07/20/2026
Richard Shannon Craig-Hallum	Hold	Reiterated	-	-	07/06/2026
Tristan Gerra Robert W. Baird	Buy	Maintained	$20.00	+75%	05/04/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	10.11M	7.30M	8.60M	10.53M
Cost of goods sold	6.28M	4.51M	5.36M	6.45M
Cost of revenue	6.28M	4.51M	5.36M	6.45M
Research and development expenses	13.28M	10.19M	14.57M	13.15M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.73M	8.98M	11.25M	13.04M
Operating expense	20.74M	23.90M	30.55M	30.92M
Total operating expenses	27.03M	28.41M	35.91M	37.38M
Operating income	-16.91M	-21.11M	-27.32M	-26.85M
Other non operating income	-59.00K	10.00K	10.00K	10.00K
EBT including unusual items	-19.25M	-31.88M	-33.72M	-228.15M
EBT excluding unusual items	-15.91M	-18.75M	-25.35M	-24.74M
Income tax expense	-19.00K	-61.00K	67.00K	71.00K
Effective tax rate	0.10%	0.19%	-0.20%	-0.03%
Other operating expenses	-	-	-	-
Net income	-19.23M	-31.82M	-33.78M	-228.22M
Net profit margin	-190.21%	-436.06%	-392.94%	-2,167.52%
Earnings per share	-0.05	-0.05	-0.04	-0.04
Interest and investment income	1.39M	1.53M	1.95M	2.10M
Interest expense	-	-	-	-
Net interest expenses	1.39M	1.53M	1.95M	2.10M
Depreciation and amortization charges	-	-	-	-
EBITDA	-11.30M	-15.48M	-21.60M	-21.22M
Gain or loss from assets sale	-	168.00K	-	8.00K

Ask anything